1 January 2025 v2026.37.1 limited_company_frs_102_section_1a_v1_1_4 companies_houseSoftwarefalsetruetruetrueNo description of principal activityfalsetruexbrli:purexbrli:sharesiso4217:GBP108488402025-01-012025-12-31108488402025-12-31108488402024-12-3110848840core:WithinOneYear2025-12-3110848840core:WithinOneYear2024-12-3110848840core:AfterOneYear2025-12-3110848840core:AfterOneYear2024-12-3110848840core:ShareCapital2025-12-3110848840core:ShareCapital2024-12-3110848840core:SharePremium2025-12-3110848840core:SharePremium2024-12-3110848840core:OtherReservesSubtotal2025-12-3110848840core:OtherReservesSubtotal2024-12-3110848840core:RetainedEarningsAccumulatedLosses2025-12-3110848840core:RetainedEarningsAccumulatedLosses2024-12-3110848840bus:Director12025-01-012025-12-3110848840bus:RegisteredOffice2025-01-012025-12-3110848840core:OfficeEquipment2025-01-012025-12-31108488402024-01-012024-12-3110848840core:PlantMachinery2025-01-0110848840core:PlantMachinery2025-01-012025-12-3110848840core:PlantMachinery2025-12-3110848840core:PlantMachinery2024-12-311084884012025-01-012025-12-311084884012025-01-012025-12-3110848840countries:EnglandWales2025-01-012025-12-3110848840bus:AuditExemptWithAccountantsReport2025-01-012025-12-3110848840bus:PrivateLimitedCompanyLtd2025-01-012025-12-3110848840bus:SmallEntities2025-01-012025-12-3110848840bus:FullAccounts2025-01-012025-12-31
Company registration number:
10848840
The Gut Stuff Limited
Unaudited Filleted Financial Statements for the year ended
31 December 2025
The Gut Stuff Limited
Report to the board of directors on the preparation of the unaudited statutory financial statements of The Gut Stuff Limited
Year ended
31 December 2025
As described on the statement of financial position, the Board of Directors of
The Gut Stuff Limited
are responsible for the preparation of the
financial statements
for the year ended
31 December 2025
, which comprise the income statement, statement of financial position, statement of changes in equity and related notes.
You consider that the company is exempt from an audit under the Companies Act 2006.
In accordance with your instructions I have compiled these unaudited financial statements in order to assist you to fulfil your statutory responsibilities, from the accounting records and from information and explanations supplied to me.
Elm Financial Solutions Limited
Chartered Certified Accountants
The Gut Stuff Limited
Statement of Financial Position
31 December 2025
20252024
Note££
Fixed assets    
Tangible assets 5
2,085
 
410
 
Current assets    
Stocks
161,417
 
77,019
 
Debtors 6
84,396
 
325,560
 
Cash at bank and in hand
26,445
 
(80,194
 )
272,258
 
322,385
 
Creditors: amounts falling due within one year 7
(544,884
 )
(215,685
 )
Net current (liabilities)/assets
(272,626
 )
106,700
 
Total assets less current liabilities (270,541 ) 107,110  
Creditors: amounts falling due after more than one year 8
(204,068
 )
(100,000
 )
Provisions for liabilities -  
80
 
Net (liabilities)/assets
(474,609
 )
7,190
 
Capital and reserves    
Called up share capital
19,596
 
19,574
 
Share premium
3,930,872
 
3,919,712
 
Other reserves
245,361
 
39,946
 
Profit and loss account
(4,670,438
 )
(3,972,042
 )
Shareholders (deficit)/funds
(474,609
 )
7,190
 
For the year ending
31 December 2025
, the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
  • The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476;
  • The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
These
financial statements
have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies’ regime.
In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered.
These
financial statements
were approved by the board of directors and authorised for issue on
15 September 2026
, and are signed on behalf of the board by:
Alana MacFarlane Kempner
Director
Company registration number:
10848840
The Gut Stuff Limited
Notes to the Financial Statements
Year ended
31 December 2025

1 General information

The company is a private company limited by shares and is registered in England and Wales. The address of the registered office is
Holt Hall
,
Holt Lane
,
Matlock
, ,
DE4 3LY
, United Kingdom.
The principal activity during the year was that of an omnichannel consumer brand offering gut health products, services, and educational content across physical and digital platforms.

2 Statement of compliance

These
financial statements
have been prepared in compliance with FRS 102 Section 1A, 'The Financial Reporting Standard applicable to the UK and Republic of Ireland'.

3 Accounting policies

Basis of preparation

The
financial statements
have been prepared on the historical cost basis, as modified by the revaluation of certain assets.
The
financial statements
are prepared in sterling, which is the functional currency of the company.

Going concern

The financial statements are prepared on a going concern basis. This assumes that the company will continue in operational existence for the foreseeable future having adequate resources (including financial resources) to meet its obligations when they fall due. The validity of the going concern basis is primarily dependent upon the financial support by the parent company, Hero UK Foods Limited, a member of the Hero AG group whom acquired the entire issued share capital of the company on 22 April 2026 .
The parent company, Hero UK Foods Limited, has provided, since the period end, confirmation of their continued support and that sufficient cash will be made available to ensure that all third party creditors are paid as they fall due. In light of this, and having considered the matters above, the director believes that it is appropriate for the financial statements to be prepared under the going concern basis.
The financial statements do not include any adjustments that would result from a withdrawal of the loan.

Turnover

Turnover is measured at the fair value of the consideration received or receivable for goods supplied, net of discounts and Value Added Tax.
Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer, usually on despatch of the goods; the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.

Current tax

Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.

Research and development

Research expenditure is written off in the period in which it is incurred. Development expenditure incurred is capitalised as an intangible asset only when It is technically feasible to complete the intangible asset so that it will be available for use or sale; there is the intention to complete the intangible asset and use or sell it; there is the ability to use or sell the intangible asset; the use or sale of the intangible asset will generate probable future economic benefits; there are adequate technical, financial and other resources available to complete the development and to use or sell the intangible asset; and the expenditure attributable to the intangible asset during its development can be measured reliably. Expenditure that does not meet the above criteria is expensed as incurred.
During 2025 the company invested approximately 4% of administrative expenses (2024: 10%) in the research and development of its digital platform and product range

Tangible assets

Tangible assets are initially measured at cost, and are subsequently measured at cost less any accumulated depreciation and accumulated impairment losses or at a revalued amount.
Any tangible assets carried at a revalued amount are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses.
An increase in the carrying amount of an asset as a result of a revaluation is recognised in other comprehensive income and accumulated in capital and reserves. However, the increase is recognised in profit or loss to the extent that it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in capital and reserves. If a revaluation decrease exceeds the accumulated revaluation gains accumulated in capital and reserves in respect of that asset, the excess is recognised in profit or loss.
Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value, over the useful economic life of that asset as follows:
Office equipment
33% straight line

Impairment

A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date.

Stocks

Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost includes all costs of purchase, costs of conversion and other costs incurred in bringing the stocks to their present location and condition.

Financial instruments

A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument.
Basic financial instruments are initially recognised at the transaction price and are subsequently measured as follows: Debt instruments are subsequently measured at amortised cost and commitments to receive a loan and to make a loan to another entity are subsequently measured at amortised cost. Where investments in non-convertible preference shares and non-puttable ordinary shares or preference shares are publicly traded or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value with changes in fair value recognised in profit or loss. All other such investments are subsequently measured at cost less impairment.
All other financial instruments, including derivatives, are initially recognised at fair value, which is normally the transaction price and are subsequently measured at fair value, with any changes recognised in profit or loss.
Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately.
All equity instruments regardless of significance, and other financial assets that are individually significant, are assessed individually for impairment. Other financial assets or either assessed individually or grouped on the basis of similar credit risk characteristics.
Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.

Provisions for liabilities

Provisions are recognised when the entity has an obligation at the reporting date as a result of a past event; it is probable that the entity will be required to transfer economic benefits in settlement and the amount of the obligation can be estimated reliably. Provisions are recognised as a liability in the statement of financial position and the amount of the provision as an expense.
Provisions are initially measured at the best estimate of the amount required to settle the obligation at the reporting date and subsequently reviewed at each reporting date and adjusted to reflect the current best estimate of the amount that would be required to settle the obligation. Any adjustments to the amounts previously recognised are recognised in profit or loss unless the provision was originally recognised as part of the cost of an asset. When a provision is measured at the present value of the amount expected to be required to settle the obligation, the unwinding of the discount is recognised in finance costs in profit or loss in the period it arises.

Share-based payments

Equity-settled share-based payment transactions are measured at fair value at the date of grant. The fair value is expensed on a straight-line basis over the vesting period, with a corresponding increase in equity. This is based upon the company's estimate of the shares or share options that will eventually vest which takes into account all vesting conditions and non-market performance conditions, with adjustments being made where new information indicates the number of shares or share options expected to vest differs from previous estimates.
Cash-settled share-based payment transactions are measured at the fair value of the liability. Until the liability is settled, the fair value of the liability is re-measured at each reporting date and at the date of settlement, with any changes in fair value recognised in profit or loss for the period.

4 Average number of employees

The average number of persons employed by the company during the year was
10
(2024:
8.00
).

5 Tangible assets

Plant and machinery etc.
£
Cost  
At
1 January 2025
7,074
 
Additions
2,066
 
At
31 December 2025
9,140
 
Depreciation  
At
1 January 2025
6,664
 
Charge
391
 
At
31 December 2025
7,055
 
Carrying amount  
At
31 December 2025
2,085
 
At 31 December 2024
410
 

6 Debtors

20252024
££
Trade debtors
69,742
 
228,743
 
Other debtors
14,654
 
96,817
 
84,396
 
325,560
 

7 Creditors: amounts falling due within one year

20252024
££
Trade creditors
77,256
 
84,701
 
Taxation and social security
3,880
 
53,702
 
Other creditors
463,748
 
77,282
 
544,884
 
215,685
 

8 Creditors: amounts falling due after more than one year

20252024
££
Bank loans and overdrafts
204,068
 
100,000
 

9 Events after the end of the reporting period

On 22 April 2026 the entire issued share capital of the company was acquired by Hero UK Foods Limited, a member of the Hero AG group. Immediately prior to completion, all outstanding share options were exercised, resulting in the issue of 134,612 ordinary shares and the transfer of the share option reserve of £245,360 to the share premium account, and the seed preferred shares were re-designated as ordinary shares. In connection with the transaction, the convertible loan notes (£204,068 at 31 December 2025) and the short-term loan (£339,814 at 31 December 2025) were settled. These are non-adjusting events and accordingly no effect has been reflected in these financial statements.